277 related articles for article (PubMed ID: 33414240)
1. Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases.
Ibrahim W; Carr L; Cordell R; Wilde MJ; Salman D; Monks PS; Thomas P; Brightling CE; Siddiqui S; Greening NJ
Thorax; 2021 May; 76(5):514-521. PubMed ID: 33414240
[TBL] [Abstract][Full Text] [Related]
2. Breathomics from exhaled volatile organic compounds in pediatric asthma.
Neerincx AH; Vijverberg SJH; Bos LDJ; Brinkman P; van der Schee MP; de Vries R; Sterk PJ; Maitland-van der Zee AH
Pediatr Pulmonol; 2017 Dec; 52(12):1616-1627. PubMed ID: 29082668
[TBL] [Abstract][Full Text] [Related]
3. Exhaled breath analysis by electronic nose in respiratory diseases.
Scarlata S; Pennazza G; Santonico M; Pedone C; Antonelli Incalzi R
Expert Rev Mol Diagn; 2015; 15(7):933-56. PubMed ID: 25959642
[TBL] [Abstract][Full Text] [Related]
4. Exhaled breath compositions under varying respiratory rhythms reflects ventilatory variations: translating breathomics towards respiratory medicine.
Sukul P; Schubert JK; Zanaty K; Trefz P; Sinha A; Kamysek S; Miekisch W
Sci Rep; 2020 Aug; 10(1):14109. PubMed ID: 32839494
[TBL] [Abstract][Full Text] [Related]
5. The versatile use of exhaled volatile organic compounds in human health and disease.
Boots AW; van Berkel JJ; Dallinga JW; Smolinska A; Wouters EF; van Schooten FJ
J Breath Res; 2012 Jun; 6(2):027108. PubMed ID: 22621865
[TBL] [Abstract][Full Text] [Related]
6. Exhaled volatile organic compounds in adult asthma: a systematic review.
Azim A; Barber C; Dennison P; Riley J; Howarth P
Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31273044
[TBL] [Abstract][Full Text] [Related]
7. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.
Brinkman P; van de Pol MA; Gerritsen MG; Bos LD; Dekker T; Smids BS; Sinha A; Majoor CJ; Sneeboer MM; Knobel HH; Vink TJ; de Jongh FH; Lutter R; Sterk PJ; Fens N
Clin Exp Allergy; 2017 Sep; 47(9):1159-1169. PubMed ID: 28626990
[TBL] [Abstract][Full Text] [Related]
8. Breathomics: Review of Sample Collection and Analysis, Data Modeling and Clinical Applications.
Khoubnasabjafari M; Mogaddam MRA; Rahimpour E; Soleymani J; Saei AA; Jouyban A
Crit Rev Anal Chem; 2022; 52(7):1461-1487. PubMed ID: 33691552
[TBL] [Abstract][Full Text] [Related]
9. Breath volatile organic compounds (VOCs) as biomarkers for the diagnosis of pathological conditions: A review.
Moura PC; Raposo M; Vassilenko V
Biomed J; 2023 Aug; 46(4):100623. PubMed ID: 37336362
[TBL] [Abstract][Full Text] [Related]
10. Breathomics in lung disease.
van der Schee MP; Paff T; Brinkman P; van Aalderen WMC; Haarman EG; Sterk PJ
Chest; 2015 Jan; 147(1):224-231. PubMed ID: 25560860
[TBL] [Abstract][Full Text] [Related]
11. Human Breathomics Database.
Kuo TC; Tan CE; Wang SY; Lin OA; Su BH; Hsu MT; Lin J; Cheng YY; Chen CS; Yang YC; Chen KH; Lin SW; Ho CC; Kuo CH; Tseng YJ
Database (Oxford); 2020 Jan; 2020():. PubMed ID: 31976536
[TBL] [Abstract][Full Text] [Related]
12. Sensors for detecting pulmonary diseases from exhaled breath.
Hashoul D; Haick H
Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31243097
[TBL] [Abstract][Full Text] [Related]
13. Volatile Organic Compounds in Human Breath.
Karunagaran M; Ramani P; Gheena S; Abilasha R; Hannah R
Indian J Dent Res; 2022; 33(1):100-104. PubMed ID: 35946254
[TBL] [Abstract][Full Text] [Related]
14. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
[TBL] [Abstract][Full Text] [Related]
15. Analyses of lung cancer-derived volatiles in exhaled breath and
Choueiry F; Barham A; Zhu J
Exp Biol Med (Maywood); 2022 Jul; 247(13):1179-1190. PubMed ID: 35410512
[TBL] [Abstract][Full Text] [Related]
16. The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children - clinical tools or scientific toys?
van Mastrigt E; de Jongste JC; Pijnenburg MW
Clin Exp Allergy; 2015 Jul; 45(7):1170-88. PubMed ID: 25394891
[TBL] [Abstract][Full Text] [Related]
17. Utility of volatile organic compounds as a diagnostic tool in preterm infants.
Wright H; Bannaga AS; Iriarte R; Mahmoud M; Arasaradnam RP
Pediatr Res; 2021 Jan; 89(2):263-268. PubMed ID: 32120380
[TBL] [Abstract][Full Text] [Related]
18. Exhaled Molecular Fingerprinting in Diagnosis and Monitoring: Validating Volatile Promises.
Boots AW; Bos LD; van der Schee MP; van Schooten FJ; Sterk PJ
Trends Mol Med; 2015 Oct; 21(10):633-644. PubMed ID: 26432020
[TBL] [Abstract][Full Text] [Related]
19. Influence of Sensory Stimulation on Exhaled Volatile Organic Compounds.
Mazzatenta A; Pokorski M; Di Tano A; Cacchio M; Di Giulio C
Adv Exp Med Biol; 2016; 884():75-9. PubMed ID: 26453064
[TBL] [Abstract][Full Text] [Related]
20. Exhaled breath testing - A tool for the clinician and researcher.
Davis MD; Fowler SJ; Montpetit AJ
Paediatr Respir Rev; 2019 Feb; 29():37-41. PubMed ID: 29921519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]